Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea

CompletedOBSERVATIONAL

Enrollment

1,711

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG

Exenatide

Trial Locations (1)

Local Institution, Seoul